UroGen Pharma Ltd. (URGN) stock
URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$29.79−0.08 (-0.27%)
Close on Nov 18, 2026Market cap $1.46BP/E –Yield –
UroGen Pharma EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
UroGen Pharma's EV/EBITDA was 92.1× on Jan 31, 2018.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jan 31, 2018 | 92.1× | +27.5 |
| 2017 | Dec 29, 2017 | 64.6× | – |
See a number that looks wrong?